
TriMas Corporation (NASDAQ:TRS - Free Report) - Equities research analysts at BWS Financial upped their Q4 2025 earnings per share (EPS) estimates for TriMas in a research note issued on Wednesday, July 30th. BWS Financial analyst H. Khorsand now expects that the industrial products company will earn $0.36 per share for the quarter, up from their previous estimate of $0.33. BWS Financial currently has a "Buy" rating and a $45.00 target price on the stock. The consensus estimate for TriMas' current full-year earnings is $1.69 per share. BWS Financial also issued estimates for TriMas' Q2 2026 earnings at $0.68 EPS, Q3 2026 earnings at $0.64 EPS and FY2026 earnings at $2.22 EPS.
TriMas (NASDAQ:TRS - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The industrial products company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.50 by $0.11. The company had revenue of $274.76 million during the quarter, compared to the consensus estimate of $251.18 million. TriMas had a return on equity of 11.49% and a net margin of 3.83%. The firm's revenue for the quarter was up 14.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.43 EPS.
Separately, Wall Street Zen upgraded shares of TriMas from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st.
Check Out Our Latest Analysis on TRS
TriMas Price Performance
NASDAQ TRS traded down $0.51 during trading hours on Monday, hitting $35.02. The company had a trading volume of 221,071 shares, compared to its average volume of 413,271. TriMas has a 52 week low of $19.33 and a 52 week high of $36.77. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.44 and a current ratio of 2.59. The firm has a market capitalization of $1.42 billion, a price-to-earnings ratio of 38.45 and a beta of 0.66. The firm has a 50 day simple moving average of $29.49 and a 200 day simple moving average of $25.51.
TriMas Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, August 12th. Investors of record on Tuesday, August 5th will be issued a $0.04 dividend. This represents a $0.16 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Tuesday, August 5th. TriMas's dividend payout ratio is currently 17.58%.
Insider Activity at TriMas
In related news, Director Adrianne Shapira bought 4,000 shares of TriMas stock in a transaction dated Thursday, June 5th. The shares were acquired at an average cost of $25.82 per share, with a total value of $103,280.00. Following the completion of the transaction, the director owned 8,476 shares in the company, valued at $218,850.32. The trade was a 89.37% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Shawn Sedaghat bought 72,937 shares of the firm's stock in a transaction that occurred on Thursday, May 22nd. The shares were purchased at an average cost of $26.16 per share, for a total transaction of $1,908,031.92. Following the purchase, the director owned 1,883,758 shares in the company, valued at $49,279,109.28. This represents a 4.03% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 848,261 shares of company stock valued at $21,645,007 over the last three months. 14.20% of the stock is currently owned by insiders.
Institutional Investors Weigh In On TriMas
Institutional investors and hedge funds have recently modified their holdings of the business. Bank of America Corp DE increased its stake in TriMas by 127.3% in the fourth quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company's stock valued at $86,400,000 after purchasing an additional 1,967,738 shares in the last quarter. Irenic Capital Management LP bought a new stake in TriMas during the 1st quarter valued at $19,997,000. Alta Fox Capital Management LLC bought a new position in TriMas in the 1st quarter valued at about $17,385,000. Simcoe Capital Management LLC bought a new position in TriMas during the 1st quarter valued at $6,451,000. Finally, Raymond James Financial Inc. purchased a new position in TriMas in the fourth quarter worth $6,698,000. 99.42% of the stock is owned by institutional investors.
About TriMas
(
Get Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Articles

Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.